HYPERTROPHIC SCARS AND KELOIDS: AN UPDATED REVIEW OF PATHOPHYSIOLOGY, CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS, RISK FACTORS, AND THERAPEUTIC ADVANCES
DOI:
https://doi.org/10.67145/0d901e18Keywords:
Hypertrophic scars, Keloids, Abnormal wound healing, Transforming growth factor-beta, Fibroblasts, Intralesional corticosteroids, Scar assessment, RecurrenceAbstract
Hypertrophic scars and keloids are fibroproliferative disorders that arise from abnormal cutaneous wound healing and may cause pain, pruritus, functional limitations, disfigurement, and psychological distress. Although both conditions share several pathological features, they differ in their clinical presentation and natural history. Hypertrophic scars remain confined to the boundaries of the original wound and may gradually regress over time, whereas keloids extend beyond the wound margins, rarely resolve spontaneously, and are associated with a high risk of recurrence following surgical excision. This review provides an overview of the epidemiology, wound-healing mechanisms, molecular pathophysiology, clinical and histopathological characteristics, predisposing factors, diagnostic assessment, quality-of-life impact, preventive measures, and current therapeutic approaches for both conditions. Keloid development varies across ethnic populations and frequently demonstrates familial clustering, with genetic association studies supporting an underlying hereditary susceptibility. In contrast, hypertrophic scars are more commonly associated with burns, deep dermal injuries, delayed wound healing, and increased mechanical tension. The pathogenesis of both conditions is multifactorial and involves transforming growth factor-beta (TGF-β) signalling, persistent inflammation, mechanotransduction, vascular alterations, and epigenetic mechanisms. However, much of the available mechanistic evidence is derived from experimental models and relatively small tissue-based studies. Current management strategies include silicone-based preparations and pressure therapy for prevention and early intervention, while established lesions may require intralesional corticosteroids, 5-fluorouracil, cryotherapy, or laser-based treatments. Surgical excision combined with appropriate adjuvant therapy, including radiotherapy in selected cases, may be considered for recurrent or treatment-resistant keloids. Nevertheless, comparisons of treatment efficacy remain challenging because available studies are often limited by small sample sizes, heterogeneous outcome measures, and inadequate follow-up. Consequently, treatment should be individualized according to scar characteristics, clinical presentation, recurrence risk, and patient preferences. A combination of therapeutic approaches, validated scar assessment instruments, and long-term follow-up may help optimize clinical outcomes. Further research, particularly large-scale population-based epidemiological studies and well-designed clinical trials using standardized outcome measures, is needed to clarify disease mechanisms and establish the comparative effectiveness of emerging and existing therapeutic interventions.
References
[1] Y. Zhong et al., “Hydrogel Loaded with Components for Therapeutic Applications in Hypertrophic Scars and Keloids,” International Journal of Nanomedicine. 2024. doi: 10.2147/IJN.S448667.
[2] Y. Shen et al., “Therapeutic methods and effect on keloid and hypertrophic scars: a systematic review,” Frontiers in Medicine. 2026. doi: 10.3389/fmed.2026.1702697.
[3] M. Wu et al., “Exosomes in Hypertrophic Scars and Keloids: Mechanisms and Therapeutic Potentials—A Narrative Review,” Journal of Cosmetic Dermatology. 2026. doi: 10.1111/jocd.70705.
[4] I. Kurokawa, A. M. Layton, and R. Ogawa, “Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis,” Dermatology and Therapy. 2021. doi: 10.1007/s13555-021-00552-6.
[5] Z. Li, X. Han, and Y. Ren, “Global epidemiological and aetiological patterns of hand, foot, and mouth disease: a country-level scoping synthesis,” J. Glob. Health, 2026, doi: 10.7189/jogh.16.04220.
[6] M. S. Gawande, N. Zade, P. Kumar, S. Gundewar, I. N. Weerarathna, and P. Verma, “The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development,” Molecular Biomedicine. 2025. doi: 10.1186/s43556-024-00238-3.
[7] L. J. Ustick et al., “Metagenomic analysis reveals global-scale patterns of ocean nutrient limitation,” Science (80-. )., 2021, doi: 10.1126/science.abe6301.
[8] M. Pradhan and P. Pethe, “The Molecular Mechanisms Involved in the Hypertrophic Scars Post-Burn Injury,” Yale Journal of Biology and Medicine. 2023. doi: 10.59249/RHUF5686.
[9] U. Dube, M. Corliss, K. M. Bowling, J. W. Heusel, and C. C. Coughlin, “Age, Sex, and Anatomical Location Patterns in Cutaneous Pyogenic Granuloma Cases,” JAMA Dermatology, 2025, doi: 10.1001/jamadermatol.2024.5447.
[10] D. C. Whiteman, N. Pandeya, and C. M. Olsen, “Differences in mean age at diagnosis of invasive melanoma for men and women by anatomical site, thickness and subtype,” Br. J. Dermatol., 2025, doi: 10.1093/bjd/ljae482.
[11] J. Wegert et al., “Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor,” Genome Med., 2025, doi: 10.1186/s13073-025-01482-0.
[12] J. Lakes et al., “Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer—Introducing the Prospective ‘ProFam-Risk’ Study,” Eur. Urol. Open Sci., 2026, doi: 10.1016/j.euros.2025.12.018.
[13] J. Ji, X. Shi, E. Tang, J. Zheng, and L. Liang, “Serum Vitamin D Levels and Its Relationship With Keloid, Acne or Hypertrophic Scar: A Two-Sample Mendelian Randomization Study,” J. Cosmet. Dermatol., 2025, doi: 10.1111/jocd.70398.
[14] A. Shirode, A. S. Parihar, P. Sahu, and G. Bawane, “Seizure onset after head injury due to road traffic accident: A comprehensive case report,” Multidiscip. Sci. J., 2025, doi: 10.31893/multiscience.2025388.
[15] S. O’Reilly, E. Markiewicz, and O. C. Idowu, “Aging, senescence, and cutaneous wound healing—a complex relationship,” Frontiers in Immunology. 2024. doi: 10.3389/fimmu.2024.1429716.
[16] E. B. Schneider, “The determinants of child stunting and shifts in the growth pattern of children: A long-run, global review,” J. Econ. Surv., 2025, doi: 10.1111/joes.12591.
[17] K. Horikoshi, Y. Iimura, H. Suzuki, M. Suzuki, H. Sugano, and A. Kondo, “Spontaneous regression of epileptogenic pilocytic astrocytoma with FGFR1-TACC1 fusion,” Child’s Nerv. Syst., 2025, doi: 10.1007/s00381-025-06789-2.
[18] L. Maghiar et al., “Fitzpatrick Skin Phototype Is Independently Associated with Differential Short-Term Cutaneous Reactivity Following Standardized Topical Provocation in Humans,” Life, 2026, doi: 10.3390/life16020364.
[19] L. Braun, R. Graffeo, K. Kapilan, H. K. Mandhair, M. Rabaglio, and U. Novak, “Familial lymphoma and genetic predisposition: an updated review,” BMC Medical Genomics. 2026. doi: 10.1186/s12920-026-02411-9.
[20] L. P. He, C. Li, J. Gao, W. Zhang, L. Q. Shi, and H. L. Zhang, “Quantify typical trapping sites of deuterium in tungsten by sequential thermal desorption coupled with a dedicated numerical diffusion model,” Nucl. Fusion, 2025, doi: 10.1088/1741-4326/ad9ab8.
[21] M. T. Dwiputra et al., “Clinical outcomes in congenital talipes equinovarus treated with the Ponseti method: correlation with Dimeglio score, Pirani score, and age at presentation,” Rom. J. Pediatr., 2025, doi: 10.37897/RJP.2025.2.3.
[22] M. C. Eisma and A. Buyukcan-Tetik, “Prolonged Grief Symptoms Predict Social and Emotional Loneliness and Depression Symptoms,” Behav. Ther., 2025, doi: 10.1016/j.beth.2024.04.014.
[23] A. M. Azzahra, D. S. Perdanakusuma, D. M. Indramaya, and I. D. Saputro, “Keloid and Hypertrophic Scar Post-Excision Recurrence: A Retrospective Study,” J. Plast. Rekonstruksi, 2024, doi: 10.14228/jprjournal.v9i2.343.
[24] R. Hoseini, A. Shalbaf, A. Shoeibi, and R. B. Pachori, “Application of artificial intelligence in attention-deficit hyperactivity disorder deteaction and response to treatment: A systematic review,” Biomedical Signal Processing and Control. 2025. doi: 10.1016/j.bspc.2025.108197.
[25] M. Ardan and K. Febriyanto, “Optimising hospital management through integrated epidemiological data: A study in Samarinda,” J. Kedokt. dan Kesehat. Indones., 2025, doi: 10.20885/jkki.vol16.iss2.art8.
[26] Y. Zhang et al., “Curcumin-loaded PLGA microparticles integrated with ZnO/GelMA hydrogel microneedles for infectious wound healing and reduction of hypertrophic scars,” J. Nanobiotechnology , 2025, doi: 10.1186/s12951-025-03534-4.
[27] Q. Zhang, L. Dong, S. Gong, and T. Wang, “Unraveling the landscape of m6A RNA methylation in wound healing and scars,” Cell Death Discovery. 2024. doi: 10.1038/s41420-024-02222-w.
[28] S. Zhou, M. Xie, J. Su, B. Cai, J. Li, and K. Zhang, “New insights into balancing wound healing and scarless skin repair,” Journal of Tissue Engineering. 2023. doi: 10.1177/20417314231185848.
[29] Y. K. Hong, Y. H. Chang, Y. C. Lin, B. Chen, B. E. K. Guevara, and C. K. Hsu, “Inflammation in Wound Healing and Pathological Scarring,” Adv. Wound Care, 2023, doi: 10.1089/wound.2021.0161.
[30] G. Grabowski, M. J. Pacana, and E. Chen, “Keloid and Hypertrophic Scar Formation, Prevention, and Management: Standard Review of Abnormal Scarring in Orthopaedic Surgery,” The Journal of the American Academy of Orthopaedic Surgeons. 2020. doi: 10.5435/JAAOS-D-19-00690.
[31] H. Venugopal, A. Hanna, C. Humeres, and N. G. Frangogiannis, “Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction,” Cells. 2022. doi: 10.3390/cells11091386.
[32] Z. S. C. S. Froom, N. I. Callaghan, and L. Davenport Huyer, “Cellular crosstalk in fibrosis: Insights into macrophage and fibroblast dynamics,” Journal of Biological Chemistry. 2025. doi: 10.1016/j.jbc.2025.110203.
[33] A. O. Giarratana, C. M. Prendergast, M. M. Salvatore, and K. M. Capaccione, “TGF-β signaling: critical nexus of fibrogenesis and cancer,” Journal of Translational Medicine. 2024. doi: 10.1186/s12967-024-05411-4.
[34] K. A. Sheikh et al., “Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies,” OncoTargets and Therapy . 2025. doi: 10.2147/OTT.S493643.
[35] S. Poletti, M. G. Mazza, and F. Benedetti, “Inflammatory mediators in major depression and bipolar disorder,” Translational Psychiatry. 2024. doi: 10.1038/s41398-024-02921-z.
[36] L. Al-Mansoori, H. Al-Jaber, M. S. Prince, and M. A. Elrayess, “Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance,” Inflammation. 2022. doi: 10.1007/s10753-021-01559-z.
[37] B. Ahmed, A. A. Rahman, S. Lee, and R. Malhotra, “The Implications of Aging on Vascular Health,” International Journal of Molecular Sciences. 2024. doi: 10.3390/ijms252011188.
[38] J. Örling, K. Kosonen, J. Villman, M. Reichard, and I. Paatero, “Impaired fin regeneration and angiogenesis in aged zebrafish and turquoise killifish,” Biol. Open, 2023, doi: 10.1242/bio.059622.
[39] S. G. Rajan, P. Roca-Cusachs, and P. Niethammer, “Mechanotransduction by nuclear envelope tension,” Nucleus. 2026. doi: 10.1080/19491034.2025.2600901.
[40] R. Cao, H. Tian, Y. Tian, and X. Fu, “A Hierarchical Mechanotransduction System: From Macro to Micro,” Advanced Science. 2024. doi: 10.1002/advs.202302327.
[41] S. C. A. Hanssen, M. M. B. Seyger, P. E. J. Van Erp, C. J. M. Van der Vleuten, and P. C. M. Van de Kerkhof, “Hypoxia and oxidative stress related to inflammation and vascular aspects of the pathogenesis of psoriasis,” Skin Health and Disease. 2026. doi: 10.1093/skinhd/vzaf007.
[42] E. Damaskopoulou, L. Papageorgiou, E. Eliopoulos, G. Chrousos, and D. Vlachakis, “Genetic and epigenetic mechanisms associated with child abuse: A bioinformatics study,” Int. J. Epigenetics, 2025, doi: 10.3892/ije.2025.27.
[43] G. C. Limandjaja, J. M. Belien, R. J. Scheper, F. B. Niessen, and S. Gibbs, “Hypertrophic and keloid scars fail to progress from the CD34−/α-smooth muscle actin (α-SMA)+ immature scar phenotype and show gradient differences in α-SMA and p16 expression,” Br. J. Dermatol., 2020, doi: 10.1111/bjd.18219.
[44] J. Bailey, M. Schwehr, and A. Beattie, “Management of Keloids and Hypertrophic Scars,” Am. Fam. Physician, 2024.
[45] Y. Zou et al., “Role of the TGF‑β/Smad signaling pathway in the transition from acute kidney injury to chronic kidney disease (Review),” International Journal of Molecular Medicine. 2025. doi: 10.3892/ijmm.2025.5603.
[46] F. S. Younesi, A. E. Miller, T. H. Barker, F. M. V. Rossi, and B. Hinz, “Fibroblast and myofibroblast activation in normal tissue repair and fibrosis,” Nature Reviews Molecular Cell Biology. 2024. doi: 10.1038/s41580-024-00716-0.
[47] H. Zhou et al., “Human extracellular matrix (ECM)-like collagen and its bioactivity,” Regen. Biomater., 2024, doi: 10.1093/rb/rbae008.
[48] L. Yang, J. Lu, Z. Zhao, Z. Zhang, W. Yang, and G. Zhang, “Research Progress on Inflammation and Immune Dysregulation in PTSD,” Brain and Behavior. 2025. doi: 10.1002/brb3.70633.
[49] L. Liu, J. Yu, Y. Liu, L. Xie, F. Hu, and H. Liu, “Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors,” Frontiers in Cell and Developmental Biology. 2025. doi: 10.3389/fcell.2025.1572909.
[50] S. Li, W. Liu, X. Chen, Z. Chen, J. Shi, and J. Hua, “From Hypoxia to Oxidative Stress: Antioxidants’ Role to Reduce Male Reproductive Damage,” Reproductive Sciences. 2025. doi: 10.1007/s43032-024-01746-x.
[51] V. Ercegović, M. Džimbeg, and A. Gelemanović, “Genetic Susceptibility of Type 2 Diabetes and Metabolic Syndrome,” Diabetology. 2025. doi: 10.3390/diabetology6020011.
[52] C. Voros et al., “Epigenetic Alterations in Ovarian Function and Their Impact on Assisted Reproductive Technologies: A Systematic Review,” Biomedicines. 2025. doi: 10.3390/biomedicines13030730.
[53] B. G. Peng, Y. C. Li, and L. Yang, “Role of neurogenic inflammation in intervertebral disc degeneration,” World Journal of Orthopedics. 2025. doi: 10.5312/wjo.v16.i1.102120.
[54] S. Yaşar, İ. Erdim, and A. B. Bilir, “Is There a Relationship Between Styloid Process Morphology and Symptoms Associated With Eagle Syndrome?,” Ann. Otol. Rhinol. Laryngol., 2025, doi: 10.1177/00034894251349387.
[55] V. T. Mitkova-Hristova and M. A. Atanassov, “Etiology and Anatomical Location of Uveitis—Prognostic Factors for Disease Course and Laterality,” Life, 2025, doi: 10.3390/life15060882.
[56] P. Narang et al., “The Evolution of 3D Anatomical Models: A Brief Historical Overview,” World Neurosurgery. 2021. doi: 10.1016/j.wneu.2021.07.133.
[57] D. Valeyre et al., “Differential diagnosis of pulmonary sarcoidosis: a review,” Frontiers in Medicine. 2023. doi: 10.3389/fmed.2023.1150751.
[58] S. Mandal, A. M. Baker, T. A. Graham, and K. Bräutigam, “The tumour histopathology ‘glossary’ for AI developers,” PLoS Comput. Biol., 2025, doi: 10.1371/journal.pcbi.1012708.
[59] X. Gong, J. Kulwatno, and K. L. Mills, “Rapid fabrication of collagen bundles mimicking tumor-associated collagen architectures,” Acta Biomater., 2020, doi: 10.1016/j.actbio.2020.03.019.
[60] R. Ben-Laouane, M. Ait-El-Mokhtar, A. Meddich, and M. Baslam, “Nodule–Microbiome Dynamics: Deciphering the Complexities of Nodule Symbiosis and the Root Microbiome,” International Journal of Molecular Sciences. 2026. doi: 10.3390/ijms27031487.
[61] M. R. Yazdani McCord et al., “From structure to multifunctional performance: Fibrous cellulose for advancing phase change materials,” Renewable and Sustainable Energy Reviews. 2026. doi: 10.1016/j.rser.2025.116612.
[62] M. Motamed Shariati, S. Khazaei, and M. Yaghoobi, “Choroidal vascularity index in health and systemic diseases: a systematic review,” International Journal of Retina and Vitreous. 2024. doi: 10.1186/s40942-024-00607-8.
[63] R. Agarwal et al., “Human epidermis organotypic cultures, a reproducible system recapitulating the epidermis in vitro,” Exp. Dermatol., 2023, doi: 10.1111/exd.14823.
[64] M. Chaturvedi et al., “Descriptive Epidemiology of Ovarian Cancers in India: A Report from National Cancer Registry Programme,” Indian J. Gynecol. Oncol., 2023, doi: 10.1007/s40944-022-00694-1.
[65] A. Spada et al., “Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior,” Neuroendocrinology, 2022, doi: 10.1159/000514862.
[66] S. Abdelaziz, I. Yasser, M. Amgad, M. Al Qudah, and R. Kunnath Menon, “Evaluation of the diagnostic reliability of an AI prototype in detecting clinical features from dental photographs—original research,” Front. Dent. Med., 2026, doi: 10.3389/fdmed.2026.1814876.
[67] T. Murakami and S. Shigeki, “Pharmacotherapy for Keloids and Hypertrophic Scars,” International Journal of Molecular Sciences. 2024. doi: 10.3390/ijms25094674.
[68] B. M. Davies, A. R. Carter, and D. A. Brindley, “A scoping review of the treatment of hypertrophic scars and keloids,” Dermatological Rev., 2024, doi: 10.1002/der2.118.
[69] H. H. Hayyawi and H. R. Al-Hamamy, “Dermoscopic features of hypertrophic scars and keloids,” J. Pakistan Assoc. Dermatologists, 2023, doi: 10.66344/jpad.v33i3.2286.
[70] R. Ogawa and S. Akaishi, “Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis – Keloids and hypertrophic scars may be vascular disorders,” Med. Hypotheses, 2016, doi: 10.1016/j.mehy.2016.09.024.
[71] S. W. Kim, “Management of keloid scars: Noninvasive and invasive treatments,” Archives of Plastic Surgery. 2022. doi: 10.5999/aps.2020.01914.
[72] L. Mayiwar, E. Asutay, G. Tinghög, D. Västfjäll, and K. Barrafrem, “Determinants of digital well-being,” AI Soc., 2025, doi: 10.1007/s00146-024-02071-2.
[73] C. Mudunna et al., “Nature, prevalence and determinants of mental health problems experienced by adolescents in south Asia: a systematic review,” Lancet Reg. Heal. - Southeast Asia, 2025, doi: 10.1016/j.lansea.2025.100532.
[74] D. M. Griffith, A. Towfighi, S. M. Manson, E. L. Littlejohn, and L. E. Skolarus, “Determinants of Inequities in Neurologic Disease, Health, and Well-being: The NINDS Social Determinants of Health Framework,” Neurology, 2023, doi: 10.1212/WNL.0000000000207566.
[75] S. Harding et al., “The Determinants of young Adult Social well-being and Health (DASH) study: diversity, psychosocial determinants and health,” Social Psychiatry and Psychiatric Epidemiology. 2015. doi: 10.1007/s00127-015-1047-9.
[76] E. Aalto, T. Kuosa, and M. Stucki, “Generating sets of diverse and plausible scenarios through approximated multivariate normal distributions,” Eur. J. Oper. Res., 2025, doi: 10.1016/j.ejor.2024.08.003.
[77] K. A. Walther, J. A. H. Vogler, B. Wöstmann, and S. Gröger, “Periodontal inflammation indices in association to systemic diseases,” Journal of Dentistry. 2026. doi: 10.1016/j.jdent.2026.106630.
[78] L. Boldeanu et al., “Gut Microbiome Dysbiosis in Atopic Dermatitis: Pathogenic Mechanisms, Gut–Skin Axis Disruption, and Emerging Microbiota-Targeted Therapies,” Biomedicines. 2026. doi: 10.3390/biomedicines14081711.
[79] A. Kamalova et al., “Coexistence of acid sphingomyelinase deficiency type A/B and Arnold-Chiari malformation: a novel case report,” Front. Pediatr., 2025, doi: 10.3389/fped.2025.1649007.
[80] P. Malliaras et al., “Diagnostic domains, differential diagnosis and conditions requiring further medical attention that are considered important in the assessment for Achilles tendinopathy: A Delphi consensus study,” Br. J. Sports Med., 2025, doi: 10.1136/bjsports-2024-109185.
[81] M. Takase et al., “Associations of family history of hypertension, genetic, and lifestyle risks with incident hypertension,” Hypertens. Res., 2025, doi: 10.1038/s41440-025-02314-9.
[82] W. S. Siu, H. Ma, and P. C. Leung, “Review on Current Advancements in Facilitation of Burn Wound Healing,” Bioengineering. 2025. doi: 10.3390/bioengineering12040428.
[83] P. Kumar et al., “Degradation of the mechanical properties of NbMoTaW refractory high-entropy alloy in tension,” Acta Mater., 2024, doi: 10.1016/j.actamat.2024.120297.
[84] M. J. Carter, J. DaVanzo, R. Haught, M. Nusgart, D. Cartwright, and C. E. Fife, “Chronic wound prevalence and the associated cost of treatment in Medicare beneficiaries: changes between 2014 and 2019,” J. Med. Econ., 2023, doi: 10.1080/13696998.2023.2232256.
[85] M. H. Rahbar et al., “Younger age of stroke in low-middle income countries is related to healthcare access and quality,” Annals of Clinical and Translational Neurology. 2022. doi: 10.1002/acn3.51507.
[86] “Decoding the complexity of delayed wound healing following Enterococcus faecalis infection,” Elife, 2024, doi: 10.7554/elife.95113.
[87] R. Boyapati, S. A. Cherukuri, R. Bodduru, and A. Kiranmaye, “Influence of female sex hormones in different stages of women on periodontium,” Journal of Mid-Life Health. 2021. doi: 10.4103/jmh.jmh_142_21.
[88] Abirami B., Bhuvaneshwari BB., Juala C., Abirami T., and Sri S., “Study On Association Of Skin Colour With Gingival Pigmentation Using Skin Phototype Scale, Melanin And Gingival-Melanin Pigmentation Index,” IOSR J. Dent. Med. Sci. e-ISSN, 2025.
[89] D. L. Guguluș et al., “The Epidemiology of Acne in the Current Era: Trends and Clinical Implications,” Cosmetics. 2025. doi: 10.3390/cosmetics12030106.
[90] P. Villanueva et al., “Safety of BCG vaccination and revaccination in healthcare workers,” Hum. Vaccines Immunother., 2023, doi: 10.1080/21645515.2023.2239088.
[91] F. J. Charchar et al., “Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension,” J. Hypertens., 2024, doi: 10.1097/HJH.0000000000003563.
[92] X. Hao et al., “Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease,” Annals of Medicine. 2025. doi: 10.1080/07853890.2025.2464223.
[93] S. Cortese et al., “Latest clinical frontiers related to autism diagnostic strategies,” Cell Reports Medicine. 2025. doi: 10.1016/j.xcrm.2024.101916.
[94] D. Eberhard, C. Gillberg, and E. Billstedt, “Cognitive functioning in adult psychiatric patients with and without attention-deficit/hyperactivity disorder,” Brain Behav., 2024, doi: 10.1002/brb3.3626.
[95] F. M. Kemme, A. Mieras, J. C. F. Ket, A. Meij-De Vries, P. P. M. Van Zuijlen, and A. Pijpe, “How to Assess Scar Quality in Pediatric Burn Patients: A Systematic Review on the Type and Content of Outcome Measurement Instruments,” Journal of Burn Care and Research. 2025. doi: 10.1093/jbcr/iraf048.
[96] G. V. Oliveira, D. Chinkes, C. Mitchell, G. Oliveras, H. K. Hawkins, and D. N. Herndon, “Objective assessment of burn scar vascularity, erythema, pliability, thickness, and planimetry,” Dermatologic Surg., 2005, doi: 10.1097/00042728-200501000-00010.
[97] H. Y. L. Wihastyoko, S. Soeharto, E. Widjajanto, K. Handono, and B. Pardjianto, “Modification of the Vancouver Scar Scale (VSS) score for Scarring Assessment using Rattus novergicus Abnormal Scar Model,” Res. J. Pharm. Technol., 2022, doi: 10.52711/0974-360X.2022.00219.
[98] E. S. Sinaga, M. Hatibie, M. C. Oley, and F. G. Langi, “Penilaian Parut Hipertrofi Luka Bakar Berdasarkan Patient and Observer Scar Assessment Scales (POSAS),” Med. Scope J., 2023, doi: 10.35790/msj.v6i1.46566.
[99] A. Verdelli, P. Bonan, I. Fusco, F. Madeddu, and D. Piccolo, “Striae Distensae: Clinical Results and Evidence-Based Evaluation of a Novel 675 nm Laser Wavelength,” Med., 2023, doi: 10.3390/medicina59050841.
[100] M. C. Nelson et al., “Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositis,” PLoS One, 2026, doi: 10.1371/journal.pone.0343708.
[101] I. A. Halip et al., “The Role of Dermoscopy and High-Frequency Ultrasonography in the Diagnosis and Monitoring of Psoriasis Vulgaris,” Medicina (Lithuania). 2025. doi: 10.3390/medicina61111978.
[102] Y. Ma, S. Jamdade, L. Konduri, and H. Sailem, “AI in Histopathology Explorer for comprehensive analysis of the evolving AI landscape in histopathology,” npj Digit. Med., 2025, doi: 10.1038/s41746-025-01524-2.
[103] H. Hussain, A. Keetharuth, A. Wailoo, and D. Rowen, “Enhancing HRQoL assessment for economic evaluation in dementia populations,” Alzheimer’s Dement. Transl. Res. Clin. Interv., 2025, doi: 10.1002/trc2.70061.
[104] R. Bhargava, “Digital Histopathology by Infrared Spectroscopic Imaging,” Annual Review of Analytical Chemistry. 2023. doi: 10.1146/annurev-anchem-101422-090956.
[105] V. Ebenezer, P. Ganesh, and M. Vinayagar, “Clinical outcomes, complications and impact on quality of life following orthognathic surgery: a systematic review,” Frontiers in Oral Health. 2026. doi: 10.3389/froh.2026.1790589.
[106] H. Iwasaki, H. Yagyu, and H. Shimano, “A Comprehensive Analysis of Diabetic Complications and Advances in Management Strategies,” Journal of Atherosclerosis and Thrombosis. 2025. doi: 10.5551/jat.65551.
[107] S. Chapuis, L. Ouchchane, O. Metz, L. Gerbaud, and F. Durif, “Impact of the motor complications of Parkinson’s disease on the quality of life,” Mov. Disord., 2005, doi: 10.1002/mds.20279.
[108] R. Ogawa, “The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago,” Plast. Reconstr. Surg., 2022, doi: 10.1097/PRS.0000000000008667.
[109] Z. C. Wang et al., “The Roles of Inflammation in Keloid and Hypertrophic Scars,” Frontiers in Immunology. 2020. doi: 10.3389/fimmu.2020.603187.
[110] H. Mortada et al., “Efficacy of botulinum toxin type A injections in improving hypertrophic scarring and keloid formation: A systematic review and meta-analysis of randomized controlled trials,” Journal of Cutaneous and Aesthetic Surgery. 2025. doi: 10.25259/jcas_34_2024.
[111] B. M. Hamooya, L. Siame, L. Muchaili, S. K. Masenga, and A. Kirabo, “Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches,” Frontiers in Nutrition. 2025. doi: 10.3389/fnut.2025.1661603.
[112] S. E. O. Kacimi, M. Aloulou, R. Naoum, M. Moumeni, A. Kaddour, and M. S. ElSheemy, “Conservative approach for the treatment of urethral prolapse in children: case report and literature review of 278 pediatric cases,” African J. Urol., 2021, doi: 10.1186/s12301-021-00256-5.
[113] N. Kuridze et al., “Recent advances in wound healing, tissue repair, regeneration, and scar management: A literature review,” Rev. Rom. Med. Lab., 2026, doi: 10.2478/rrlm-2026-0028.
[114] S. A. Mullen et al., “Systematic Review of Intralesional Therapies for Cutaneous Warts,” JID Innovations. 2024. doi: 10.1016/j.xjidi.2024.100264.
[115] R. Raghavan, S. Shah, B. Rudagi, S. Gaikwad, S. Raut, and D. Shitole, “Comparative Evaluation of Postoperative Scarring with Nasolabial Flap Reconstruction Using Silicone Gel Versus Silicone Gel Sheet: Randomized Controlled Trial,” J. Maxillofac. Oral Surg., 2025, doi: 10.1007/s12663-024-02228-y.
[116] E. Andrews et al., “Negative Pressure Wound Therapy With Instillation and Closed Incision Negative Pressure Therapy Use in South Africa: Expert Panel Recommendations,” International Wound Journal. 2025. doi: 10.1111/iwj.70790.
[117] Á. Astasio-Picado, J. Jurado-Palomo, B. Pozo-Aranda, and P. Cobos-Moreno, “Comparative Evidence on Negative Pressure Therapy and Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers: A Systematic Review of Independent Effectiveness and Clinical Applicability,” Medicina (Lithuania). 2026. doi: 10.3390/medicina62010109.
[118] T. Kanya, S. Ponnaiah, N. Palanivel, A. N. M. M. M. M. Babu, and G. D. Somasundaram, “Comparison of Effectiveness of Intralesional Triamcinolone Acetonide with Fractional CO2 Laser Against Intralesional Triamcinolone Acetonide with Intralesional Verapamil in the Treatment of Keloids,” Indian Dermatol. Online J., 2025, doi: 10.4103/idoj.idoj_792_24.
[119] S. Saleem et al., “Comparing the Effect of Intralesional 5-Fluorouracil (5-FU) Alone Versus Intralesional 5-FU Combined With Triamcinolone Acetonide for Keloid Treatment,” Cureus, 2025, doi: 10.7759/cureus.84635.
[120] L. G N et al., “EVALUATION OF EFFICACY AND SAFETY OF INTRALESIONAL INJ BLEOMYCIN AND INJ 5- FLUOROURACIL IN THE TREATMENT OF PALMOPLANTAR WARTS,” Int. J. Drug Deliv. Technol., 2026, doi: 10.25258/ijddt.16.62s.177.
[121] S. Naaz, S. S. Amin, M. Adil, A. Verma, and S. Tauseef, “Study of Efficacy of Intralesional Triamcinolone Versus Intralesional Bleomycin in Treatment of Keloids and Hypertrophic Scars,” Przegl. Dermatol., 2025, doi: 10.5114/dr.2025.154781.
[122] J. Muhammad, N. Akhtar, M. K. Ahmad, and M. I. Anwar, “Comparison of efficacy between intralesional bleomycin and cryotherapy in plantar warts,” J. Pakistan Assoc. Dermatologists, 2019, doi: 10.66344/jpad.v29i1.1200.
[123] K. Bukhsh et al., “Comparison of Clinical Efficacy of 0.1% Intralesional Bleomycin Solution and 0.05% Intralesional bleomycin Solution in Patients with Warts,” Pakistan J. Med. Heal. Sci., 2021, doi: 10.53350/pjmhs211571680.
[124] P. Devadoss, M. Deepanjali, M. Parthiban, I. S. Ravikumar, M. Ramanathan, and S. P. Tangutur, “Intralesional Bleomycin in the Management of Low-flow Vascular Malformations - A Case Report,” Ann. Maxillofac. Surg., 2026, doi: 10.4103/ams.ams_216_25.
[125] S. Racinais et al., “Cryotherapy for treating soft tissue injuries in sport medicine: a critical review,” British Journal of Sports Medicine. 2024. doi: 10.1136/bjsports-2024-108304.
[126] P. Pudasaini, S. Paudel, G. C. Sagar, and S. Adhikari, “Cryotherapy for treatment of sporotrichosis—rapid cure with adjuvant cryotherapy: case report,” J. Med. Case Reports , 2025, doi: 10.1186/s13256-024-04955-9.
[127] I. M. Mukovozov, N. Kashetsky, and V. Richer, “Light- and laser-based treatments for granuloma annulare: A systematic review,” Photodermatology Photoimmunology and Photomedicine. 2022. doi: 10.1111/phpp.12756.
[128] G. Dipalma et al., “Laser Therapy Versus Conventional Treatments in Oral Leukoplakia: A Systematic Review of Efficacy, Recurrence, and Postoperative Outcomes,” International Journal of Dentistry. 2026. doi: 10.1155/ijod/2130179.
[129] S. Møller et al., “Minimally invasive surgical treatments versus non-surgical treatments or placebo for plantar fasciopathy: A systematic review,” Foot and Ankle Surgery. 2025. doi: 10.1016/j.fas.2025.04.009.
[130] A. Liñares, I. Sanz-Sánchez, J. Dopico, A. Molina, J. Blanco, and E. Montero, “Efficacy of adjunctive measures in the non-surgical treatment of peri-implantitis: A systematic review,” Journal of Clinical Periodontology. 2023. doi: 10.1111/jcpe.13821.
[131] A. Lapierre and P. Blanchard, “Adaptive radiotherapy, promises and pitfalls,” Cancer/Radiotherapie. 2025. doi: 10.1016/j.canrad.2025.104677.
[132] F. Trevisan, G. F. Kalkmann, I. D. P. Nascimento, and E. L. B. Filho, “Pain tolerance and aesthetic result of removing acrochordons with contact cryotherapy compared to electrocoagulation,” Surg. Cosmet. Dermatology, 2020, doi: 10.5935/scd1984-8773.20201233677.
[133] K. Dhaliwal, T. Parks, C. Brewster, and S. Singh, “Intralesional cryotherapy for treatment of keloid scars: patient-reported outcomes,” J. Wound Care, 2025, doi: 10.12968/jowc.2021.0087.
[134] Q. Zhai, S. Cheng, R. Liu, J. Xie, X. Han, and Z. Yu, “Meta-Analysis of the Efficacy of Intense Pulsed Light and Pulsed-Dye Laser Therapy in the Management of Rosacea,” Journal of Cosmetic Dermatology. 2024. doi: 10.1111/jocd.16549.
[135] E. Balazic, A. Muskat, Y. Kost, J. L. Cohen, and K. Kobets, “The role of laser and energy-assisted drug delivery in the treatment of alopecia,” Lasers in Medical Science. 2024. doi: 10.1007/s10103-024-04015-0.
[136] C. I. Cucu et al., “Wound closure techniques after wide excision for hidradenitis suppurativa: a systematic review and meta-analysis,” International Journal of Dermatology. 2025. doi: 10.1111/ijd.17553.
[137] N. G. Lawera et al., “Keloid Intralesional Excision Reduces Recurrence: A Meta-analytic Study of the Available Literature on 608 Keloids,” Plast. Reconstr. Surg. - Glob. Open, 2024, doi: 10.1097/GOX.0000000000005652.
[138] L. A. Walsh et al., “Keloid treatments: an evidence-based systematic review of recent advances,” Systematic Reviews. 2023. doi: 10.1186/s13643-023-02192-7.
[139] Y. Xie et al., “Recent progress of hydrogel-based local drug delivery systems for postoperative radiotherapy,” Frontiers in Oncology. 2023. doi: 10.3389/fonc.2023.1027254.
[140] J. K. Appiah et al., “Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review,” Journal of Clinical Medicine. 2025. doi: 10.3390/jcm14176119.
[141] H. J. Kim and Y. H. Kim, “Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies,” International Journal of Molecular Sciences. 2024. doi: 10.3390/ijms25105302.
[142] A. G. M. Patel, P. Li, N. Badrish, A. Kesari, and K. B. Shah, “Transthyretin Cardiac Amyloidosis: Current and Emerging Therapies,” Curr. Cardiol. Rep., 2025, doi: 10.1007/s11886-024-02172-w.
[143] Y. Furukawa, K. Imai, Y. Takahashi, O. Efthimiou, and S. Leucht, “Comparative Efficacy and Acceptability of Treatment Strategies for Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-analysis,” Schizophr. Bull., 2026, doi: 10.1093/schbul/sbae098.
[144] M. Overstijns, S. Nazeeruddin, P. Scheffler, R. Roelz, J. Beck, and A. El Rahal, “Comparative Analysis of AI Models in Predicting Treatment Strategies for Unruptured Intracranial Aneurysms,” Brain Sci., 2025, doi: 10.3390/brainsci15101061.
[145] A. Majoor, G. Michel, P. Marty, L. Boyer, and C. Pomares, “Leishmaniases: Strategies in treatment development,” Parasite. 2025. doi: 10.1051/parasite/2025009.
[146] K. L. Rialon et al., “Comparative effectiveness of treatment strategies for severe splenic trauma in the pediatric population,” Am. J. Surg., 2016, doi: 10.1016/j.amjsurg.2015.06.009.
[147] B. L. Xie, J. Du Wei, J. Xiong, B. Zhong, Q. X. Ai, and D. Yang, “Comparative analysis of different treatment strategies for septic spondylitis: a retrospective study of one hundred and twelve patients,” Int. Orthop., 2024, doi: 10.1007/s00264-024-06247-9.
[148] W. Sun et al., “Clinical characteristics and factors associated with recurrence and long-term prognosis in patients with MOGAD,” Front. Immunol., 2025, doi: 10.3389/fimmu.2025.1535571.
[149] B. Liu et al., “Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy,” Front. Oncol., 2023, doi: 10.3389/fonc.2023.1106333.
[150] G. Stronati et al., “Long-term prognosis of pure and impure tachycardiomyopathy,” ESC Hear. Fail., 2025, doi: 10.1002/ehf2.15444.
[151] K. Qi et al., “Emerging research insights and future perspectives on the advancement of eccDNA: A comprehensive review,” Biotechnology Advances. 2025. doi: 10.1016/j.biotechadv.2025.108693.
[152] S. J. Sinha, B. Kumar, C. P. Prasad, S. S. Chauhan, and M. Kumar, “Emerging Research and Future Directions on Doxorubicin: A Snapshot,” Asian Pacific J. Cancer Prev., 2025, doi: 10.31557/APJCP.2025.26.1.5.
[153] B. D. McDonald, J. L. Hall, J. O’Flynn, and S. van Thiel, “The future of public administration research: An editor’s perspective,” Public Adm., 2022, doi: 10.1111/padm.12829.
[154] S. Yacoub, G. Ons, and M. Khemiss, “Efficacy of botulinum toxin type A in bruxism management: A systematic review,” Dental and Medical Problems. 2025. doi: 10.17219/dmp/186553.
[155] X. Zhang, B. Zhou, Y. Gong, and Y. Liu, “Investigation into the pharmacodynamics and pharmacokinetics of recombinant human interferon alfa-2b vaginal suppository following process optimization in chinese rhesus macaque,” Sci. Rep., 2025, doi: 10.1038/s41598-025-98813-3.
[156] M. Skerlev, I. Č. Košćak, S. L. Hadžavdić, and M. Sirotković-Skerlev, “Imiquimod,” in European Handbook of Dermatological Treatment, 2023. doi: 10.1007/978-3-031-15130-9_149.
[157] R. H. Mekky et al., “Transforming Growth Factor-β Pathway: Biological Functions and Therapeutic Targets,” MedComm. 2025. doi: 10.1002/mco2.70278.
[158] N. Hassan, B. Greve, and M. Götte, “The role of ECM mechanics in cancer mechanotransduction through unraveling the molecular machinery of integrins, FAK, and YAP signaling,” Cellular and Molecular Biology Letters. 2026. doi: 10.1186/s11658-026-00905-z.
[159] K. Mariniello and L. Guasti, “Towards novel treatments for adrenal diseases: Cell- and gene therapy-based approaches,” Mol. Cell. Endocrinol., 2021, doi: 10.1016/j.mce.2021.111160.
[160] R. Williams, H. Cauldbeck, and V. Kearns, “Sustained-release drug delivery systems,” Eye (Basingstoke). 2025. doi: 10.1038/s41433-024-03134-w.
[161] I. Campana et al., “Genetic Markers of Tumor Multiplicity in Non-melanoma Skin Cancer: Associations of 19 SNPs in an Italian Cohort,” Dermatol. Ther. (Heidelb)., 2026, doi: 10.1007/s13555-026-01740-y.
[162] J. Luo, C. Zheng, J. Yin, and H. H. Teo, “Design and assessment of AI-based learning tools in higher education: a systematic review,” International Journal of Educational Technology in Higher Education. 2025. doi: 10.1186/s41239-025-00540-2.
[163] K. Kuntal and N. Singh, “Gut Microbiome-Malaria Axis: Mechanism, Clinical Implications and Research Gaps,” J. Clin. Immunol. Microbiol., 2026, doi: 10.46889/jcim.2026.7109.
[164] S. A. Ali, D. Pathak, and S. Mandal, “INTERNATIONAL JOURNAL OF COVID-19 AND THEIR RELATIONSHIP WITH ENVIRONMENT,” vol. 14, no. 1, pp. 1–5, 2023.
[165] A. J. Kember et al., “Maternal posture-physiology interactions in human pregnancy: a narrative review,” Frontiers in Physiology. 2024. doi: 10.3389/fphys.2024.1370079.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Journal of Population Therapeutics and Clinical Pharmacology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.